Related Experiment Video
Updated: Mar 28, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Surveillance of Bacterial Meningitis, Ethiopia, 2012-2013
Abstract:
Among 139 patients with suspected bacterial meningitis in Ethiopia, 2012-2013, meningococci (19.4%) and pneumococci (12.9%) were the major disease-causing organisms. Meningococcal serogroups detected were A (n = 11), W (n = 7), C (n = 1), and X (n = 1). Affordable, multivalent meningitis vaccines for the African meningitis belt are urgently needed.
Insights
Meningococci and pneumococci were the primary causes of bacterial meningitis in Ethiopia. The study highlights an urgent need for affordable, multivalent meningitis vaccines in the African meningitis belt.
Area of Science:
- Epidemiology
- Infectious Diseases
- Vaccinology
Background:
- Bacterial meningitis remains a significant public health concern in the African meningitis belt.
- Ethiopia faces a substantial burden of meningitis, necessitating identification of causative agents.
Purpose of the Study:
- To identify the predominant bacterial pathogens responsible for meningitis in Ethiopian patients.
- To determine the serogroups of Neisseria meningitidis causing infections.
- To inform vaccine development and public health strategies.
Main Methods:
- Retrospective analysis of bacterial meningitis cases in Ethiopia from 2012-2013.
- Laboratory identification of causative organisms including Neisseria meningitidis and Streptococcus pneumoniae.
- Serogrouping of detected Neisseria meningitidis isolates.
Main Results:
- Out of 139 patients, Neisseria meningitidis (meningococci) was identified in 19.4% and Streptococcus pneumoniae (pneumococci) in 12.9%.
- Detected meningococcal serogroups included A (n=11), W (n=7), C (n=1), and X (n=1).
- Serogroup A was the most prevalent meningococcal serogroup identified.
Conclusions:
- Meningococci and pneumococci are key bacterial pathogens causing meningitis in this Ethiopian cohort.
- The identified serogroup distribution underscores the need for broad-spectrum meningitis vaccines.
- Development of affordable, multivalent vaccines is critical for controlling meningitis in the African meningitis belt.
More Related Videos
12:58Visualisation and Quantification of Intracellular Interactions of Neisseria meningitidis and Human α-actinin by Confocal Imaging
Published on: October 24, 2010
06:26Analyzing the Permeability of the Blood-Brain Barrier by Microbial Traversal through Microvascular Endothelial Cells
Published on: February 14, 2020
Related Concept Videos
Viral Meningitis
Mechanism of Antibiotic Resistance in MRSA